Infectious Disease

Abacavir/dolutegravir/lamivudine is a fixed-dose combination containing two nucleoside reverse transcriptase inhibitors (NRTIs) and integrase strand transfer inhibitor (INSTI).

Patients who were vaccinated and reinfected showed symptoms of few lesions, little mucosal disease, and minimal analgesia requirements.

Previous clinical data has shown that the vaccine also generates a strong response to the EG.5 and FL.1.5.1 variants.

The CDC and WHO are currently tracking several variants that are driving the majority of new cases around the world.

The respiratory syncytial virus vaccine (Abrysvo) is the first and only maternal RSV vaccine used to help protect infants from the virus.

A recent study found that Infants younger than 3 months, those born prematurely, and those who were publicly insured were at a higher risk for intubation.

PXVX0317 has received Fast Track and Breakthrough Therapy designation from the FDA.

Chronic pain is among the comorbidities for people diagnosed with HIV, but there has been a lack of data on the prevalence and risk factors in women.

A 510(k) clearance, or a Premarket Notification, requires device manufacturers to notify the FDA at least 90 days ahead of registration with their intent to market a medical device.

Children who tested positive were more likely to report long COVID symptoms at 90 days than children who tested negative.

According to the CDC, HPV is the most commonly sexually transmitted infection in the US, with a prevalence of 45.2% of men and 39.9% of women aged 18-59 in 2013-2014.

Demetre Daskalakis, MD, MPH, urged those in the LGBTQ+ community to get fully vaccinated against the disease.

Investigators said that RSV-prevention products and socioeconomic determinants of health for AI/AN children are “urgently needed.”

Ycanth (cantharidin) was approved for the topical treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older as an in-office administered therapy.

A study examined STI rates following doxycycline post-exposure prophylaxis to see if it could reduce infection rates.

Vaccination can minimize health care costs associated with influenza.

A new study has been published in which researchers attest to the importance of screening vigilance in regards to HIV and HBV.

Underlying HIV infection was independently associated with neurocognitive long COVID symptoms.

The FDA’s Antimicrobial Drugs Advisory Committee decided to recommend nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.

The newly approved at-home test was effective in trials, correctly identifying 98.7% of negative and 92.9% of positive samples for individuals with symptoms of upper respiratory infection.

Screening and treating immigrants for hepatitis C virus infection may be instrumental to eliminating the disease in Canada.

Researchers found an increased occurrence of CDI in individuals who were prescribed antidepressants.

The antibiotic, marketed as Xacduro, is indicated for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii.

Active tobacco use and BMI were inversely related to the risk of developing IPD.

Patients should be screened regardless of age, gender, or time of year.

Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.

Prevnar 20 contains 20 serotypes and grants the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine.

Data was presented at the 44th National Association of Pediatric Nurse Practitioners Conference regarding the effectiveness of vaccines and antivirals in preventing life threatening conditions.

The CDC said that the new guidance will help identify more cases earlier for better treatment outcomes.

Pharmacists need a depth and breadth of knowledge to get the most out of point-of-care testing for sexually transmitted infections.